Antibacterial activity of propolis against MRSA and synergism with topical mupirocin

Journal of Alternative and Complementary Medicine

Volumn 13, Issue 7, 2007, Pages 713-718

  Onlen, Yusuf ^a   Duran, Nizami ^a   Atik, Esin ^a   Savas, Lutfu ^a   Altug, Enes ^a   Yakan, Selvinaz ^a   Aslantas, Ozkan ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PROPOLIS; PSEUDOMONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; LEUKOCYTE COUNT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NOSE CARTILAGE; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTI-INFECTIVE AGENTS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; MUPIROCIN; NASAL MUCOSA; PROPOLIS; RABBITS; RANDOM ALLOCATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 35348882897     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2007.7021     Document Type: Article

References (31)

1. Fierobe L, Decre D, Muller C, et al. Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intra-abdominal infection: Relation to nasal colonization. Clin Infect Dis 1999;29:1231-1238.
2. Rubio M, Romero J, Corral O, et al. Bacteremia by Staphylococcus aureus: Analysis of 311 episodes. Enferm Infec Microbiol Clin 1999;17:56-64.
3. Lu PL, Chin LC, Peng CF, et al. Risk factors and molecular analysis of community methicillin-resistant Staphylococcus aureus carriage. J Clin Microbiol 2005;43:132-139.
4. Cole AM, Tahk A, Oren A, et al. Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol 2001;8:1064-1069.
5. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997;10:505-520.
6. von Eiff C, Becker K, Machka K, et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001;344:11-16.
7. Eltringham I. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA). [Review]. J Hosp Infect 1997;35:1-8.
8. Hudson IR. The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: A review of recent experience [Review]. J Hosp Infect 1994;27:81-98.
9. Schmitz FJ, Lindenlauf E, Hofmann B, et al. The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J Antimicrob Chemother 1998;42:489-495.
10. Hill RL, Duckworth GJ, Casewell MW. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak. J Antimicrob Chemother 1988;22:377-384.
11. Harbarth S, Dharan S, Liassine N, et al. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999;43:1412-1416.
12. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;339:520-532.
13. Harvey A. Strategies for discovering drugs from previously unexplored natural products. Drug Discov Today 2000;5:294-300.
14. Drago L, Mombelli B, De Vecchi E, et al. In vitro antimicrobial activity of propolis dry extract. J Chemother 2000;12:390-395.
15. Duran N, Koc A, Oksuz H, et al. The protective role of topical propolis on experimental keratitis via nitric oxide levels in rabbits. Mol Cell Biochem 2006;281:153-161.
16. Oksuz H, Duran N, Tamer C, et al. Effect of propolis in the treatment of experimental Staphylococcus aureus keratitis in rabbits. Ophthalmic Res 2005;37:328-334.
17. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard: M7-A4. Villanova, PA: National Committee for Clinical Laboratory Standards, 1997.
18. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982;97:309-317.
19. Bertino JS Jr. Intranasal mupirocin for outbreaks of methicillin- resistant Staphylococcus aureus. Am J Health Syst Pharm 1997;54:2185-2191.
20. Paulsen IT, Firth N, Skurray RA. Resistance to antimicrobial agents other than β-lactams. In: Crossley KB, Archer GL, eds. The Staphylococci in Human Disease. New York: Churchill Livingston Inc., 1997:175-212.
21. Mitchel BA, Brown MH, Skurray RA. QacA multidrug efflux pomp from Staphylococcus aureus: Comperative analysis of resistance to diamines, biguanides, and buanyl-hydrazones. Antimicrob Agents Chemother 1998;42:475-477.
22. Rahman M, Connolly S, Noble WC, et al. Diversity of staphylococci exhibiting high-level resistance to mupirocin. J Med Microbiol 1990;33:97-100.
23. Cookson BD. Mupirocin resistance in staphylococci [Review]. J Antimicrob Chemother 1990;25:497-501.
24. Cookson BD. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice [Review]. J Antimicrob Chemother 1998;41:11-18.
25. Allahverdiyev A, Duran N, Ozguven M, et al. Antiviral activity of the volatile oils of Melissa officinalis L. against Herpes simplex virus type-2. Phytomed 2004;11:657-661.
26. Xu H, Lee SF. Activity of plant flavonoids against antibiotic-resistant bacteria. Phytother Res 2001;15:39-43.
27. Mirzoeva OK, Grishanin RN, Calder PC. Antimicrobial action of propolis and some of its components: The effects on growth, membrane potential and motility of bacteria. Microbiol Res 1997;152:239-246.
28. Pepeljnjak S, Kosalec I. Galangin expresses bactericidal activity against multiple-resistant bacteria: MRSA, Enterococcus spp. and Pseudomonas aeruginosa. FEMS Microbiol Lett 2004;240:111-116.
29. Marcucci MC. Propolis: Chemical composition, biological properties and therapeutic activity. Apidologie 1995;26:83-99.
30. Burdock GA. Review of the biological properties and toxicity of bee propolis. Food Chem Toxicol 1998;36:347-363.
31. Krol W, Scheller S, Shani J, et al. Synergistic effect of ethanolic extract of propolis and antibiotics on the growth of Staphylococcus aureus. Arzneimittelforschung 1993;43:607-609.